Skip to content

Head Up Position and Murottal Therapy in Stroke Patients

The Combination Model of 30 Degree Head Up and Murottal Therapy on Blood Pressure, Pulse Rate, Respiratory Rate, Pain Degree, and Projectile Vomiting in Stroke Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07405593
Enrollment
112
Registered
2026-02-12
Start date
2026-03-01
Completion date
2026-06-30
Last updated
2026-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Head Up, Murottal Therapy

Brief summary

This study aims to evaluate the effects of a combination of a 30-degree head-up position and murottal therapy on physiological and symptom outcomes in stroke patients. The intervention is expected to influence blood pressure, pulse rate, respiratory rate, pain level, and the incidence of projectile vomiting. Stroke patients will receive standard care with the addition of the combined intervention. The results of this study may support non-pharmacological nursing interventions to improve patient comfort and clinical stability.

Detailed description

Stroke patients often experience physiological instability and discomfort, including changes in blood pressure, pulse rate, respiratory rate, pain, and nausea or vomiting. Non-pharmacological nursing interventions are needed to support patient comfort and clinical stability during acute care. Head-up positioning and murottal therapy are commonly used supportive interventions in nursing practice, but evidence regarding their combined effects remains limited. This study aims to evaluate the effects of a combination of a 30-degree head-up position and murottal therapy on blood pressure, pulse rate, respiratory rate, pain degree, and projectile vomiting in stroke patients. The study involves stroke patients receiving standard medical and nursing care, with the addition of the combined intervention as part of supportive nursing management. The head-up position will be applied at a 30-degree angle, while murottal therapy will be delivered through 30-minute audio recitation during for 3 days. Physiological parameters and symptom outcomes will be measured before and after the intervention according to the study protocol. The findings of this study are expected to contribute evidence for the use of simple, non-pharmacological nursing interventions to improve comfort and physiological responses in stroke patients.

Interventions

OTHERCombination of 30 Degree Head Up and Murottal Therapy

Participants in this group received a combination of two non-pharmacological interventions during the study period. First, participants were positioned with their heads elevated at a 30-degree angle while lying in bed to support physiological stability, including monitoring of blood pressure, pulse rate, respiratory rate, pain level, and projectile vomiting. Second, participants listened to Quranic recitation (murottal therapy) via audio recording in a quiet environment. Both interventions were administered simultaneously. Intervention sessions lasted 30 minutes for 3 days (a consistent duration and frequency for all participants in this group). Outcomes such as vital signs, pain level, and episodes of severe vomiting were monitored before and after the intervention period.

OTHERStandard Care (in control arm)

Participants in this arm receive standard nursing care according to the hospital protocol without additional head-up positioning or murottal therapy. Standard care includes routine monitoring of vital signs, medication administration, and basic supportive nursing interventions.

Sponsors

Universitas Muhammadiyah Surakarta
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

This study is conducted as an open-label trial because the non-pharmacological interventions, including 30-degree head-up positioning and murottal therapy, are clearly observable and cannot be feasibly blinded to participants, care providers, or investigators.

Intervention model description

Participants are assigned in parallel to an intervention group receiving 30-degree head-up positioning and murottal therapy or to a control group receiving standard care.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

: 1. Patients with a medical diagnosis of stroke (hemorrhagic and non-hemorrhagic). 2. Patients with systolic blood pressure above 150 mmHg. 3. Somnolence (GCS ≥ 9). 4. Muslim. 5. Patients without hearing impairment. 6. Willingness to participate and sign informed consent.

Exclusion criteria

: 1. Patients who are non-Muslim. 2. Patients with decreased consciousness (GCS \< 9). 3. Patients with heart problems. 4. Patients with psychiatric disorders. 5. Patients receiving sedative therapy during the study.

Design outcomes

Primary

MeasureTime frameDescription
Blood PressureBaseline and after completion of the 3-day interventionChange in systolic and diastolic blood pressure from baseline to after completion of the 3-day intervention.
Pulse RateBaseline and after completion of the 3-day interventionChange in pulse rate from baseline to after completion of the 3-day intervention.
Respiratory RateBaseline and after completion of the 3-day interventionChange in respiratory rate from baseline to after completion of the 3-day intervention
Pain DegreeBaseline and after completion of the 3-day interventionChange in pain score measured using the Critical-Care Pain Observation Tool (CPOT; range 0-8), where higher scores indicate more severe pain, from baseline to after completion of the 3-day intervention.
Projectile VomitingBaseline and after completion of the 3-day interventionChange in nausea and vomiting severity measured using the Rhodes Index of Nausea, Vomiting, and Retching (RINVR; range 0-32), where higher scores indicate more severe symptoms, from baseline to after completion of the 3-day intervention.

Countries

Indonesia

Contacts

CONTACTFila Diana Nurhayati, S.Kep.,Ns
j218250001@student.ums.ac.id+6281228527848

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026